The kinetics of the initiated oxidation of a model lipid (methyl oleate has been investigated in the presence of a group of new "hybrid" structures, namely, N substituted amides of salicylic acid whose struc ture contains an amide residue conjugated with, or separated by a bridging fragment (three methylene groups) from, an N phenolic substituent. The compounds also differ in the degree of screening of the OH groups. The process was initiated by thermal decomposition of azobisisobutyronitrile at 60°C (initiation rate of w i = 4.2 × 10 -8 mol L -1 s -1 ) or by UV irradiation (λ = 313-365 nm, w i = 0.6 × 10 -8 mol L -1 s -1 ). The compounds examined exhibit antiradical activity owing to the presence of the phenolic hydroxyl groups. N substituted salicylamides efficiently inhibit the overall methyl oleate oxidation process and are comparable in activity with dibunolum and α tocopherol or are superior to them. The structures in which the residues of salicyla mide and sterically hindered phenol are separated by the bridging fragment are particularly efficient. The advantages of the salicylamides absorbing at 300-365 nm manifest themselves in UV initiated oxidation. The peroxidase activity of the N substituted salicyl acid derivatives is determined by the structure of the amide moiety. The compounds examined here are new, promising, effective antioxidants, whose particular structural fragments act via different mechanisms in oxidation.
Studied using optical spectroscopy, stationary, and nanosecond laser photolysis (Nd:YAG laser 355 nm) conversion products in heptane of N-substituted amides of salicylic acid: N-(4hydroxyhydro-3,5-di-tert-butylphenyl) amide 2-hydroxy-3-t-butyl-5-ethylbenzoic acid (1), 2-(4-hydroxy-3,5-hydroxybenzoic acid)-di-tert-butylphenyl) propyl] amide (2), N-(4hydroxyphenyl) amide 2-hidroxy benzoic acid (3), and 2-hydroxy-3-t-butyl-5-ethylbenzoic acid N-[3-(4-hydroxy-3,5-di-t-butylphenyl) propyl] amide (4). It is shown that amides exist both in the unbound state and in complexes with intra-and intermolecular hydrogen bonding. Free phenolic groups of amides undergo photolysis, which leads to the formation of a triplet state and phenoxyl radicals RO•, presumably due to the absorption of the second photon by the excited singlet state. Triplet-triplet annihilation and recombination (kr ≈ 2.3Á10 8 Lmo l À1 s) are the main channels for the decay of the triplet state and radicals RO•. UV irradiation of the compounds leads to the excitation of amide groups, and radical products are not formed due to ionization of the NH bond. The process of initiated UV oxidation of the model substrate (methyloleate) in the presence of amides 1-4 was compared with the known antioxidants (AO): dibunol (2,6-di-tert-butyl-4-methylphenol) (5) and αtocopherol (6-hydroxy-2,5,7,8-tetramethyl-2-phytyl chromane) (6). It has been shown that all amides of salicylic acid (I-IV) effectively inhibit the oxidation of methyl oleate, initiated by UV irradiation. The mechanism of the inhibitory effect of compounds has been established, which is associated with the possibility of direct interaction of phenols with free radicals (antiradical activity). Testing of antiradical activity of amides (I-IV), estimated by the method of chemiluminescence, made it possible to determine the range of reaction rate constants with peroxyl radicals RO • 2 k 7 =(0. 5 2-6.86) • 10 4 mL À1 s À1. The interrelation of antioxidant properties of amides of salicylic acid (I-IV) and features of their structure is established. It was shown that the introduction of o-tert-butyl substituents and the separation of aromatic fragments by three methylene groups lead to a significant increase in antioxidant activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.